Page last updated: 2024-10-26

pentetic acid and Coronary Disease

pentetic acid has been researched along with Coronary Disease in 44 studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research Excerpts

ExcerptRelevanceReference
" The tolerance of this composite pulse to shimmering and frequency errors allows spin locking with comparatively weak RF and therefore low specific absorption rate (SAR)."1.29Myocardial suppression in vivo by spin locking with composite pulses. ( Arnold, BC; Dixon, WT; Oshinski, JN; Pettigrew, RI; Trudeau, JD, 1996)
"Acute myocardial infarctions were produced in 11 dogs by ligation of the left anterior descending coronary artery."1.27Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. ( Brasch, RC; Ehman, RL; Engelstad, BL; Higgins, CB; Lipton, MJ; Lovin, J; McNamara, MT; Sievers, R; Wesbey, GE, 1984)

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-199020 (45.45)18.7374
1990's21 (47.73)18.2507
2000's3 (6.82)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paeng, JC1
Lee, DS2
Kang, WJ1
Yang, HM1
Chung, JK2
Jeong, JM2
Chae, IH1
Lee, MM1
Lee, MC2
Bull, U1
Knesewitsch, P1
Kleinhans, E1
Seiderer, M1
Strauer, BE1
Freeman, A1
Giles, R1
McIlveen, B1
Murray, P1
Tsygankov, AT1
Lemysh, AV1
Dymond, DS1
Grenier, RP1
Carpenter, J1
Schmidt, DH1
McNamara, MT2
Higgins, CB7
Ehman, RL2
Revel, D1
Sievers, R2
Brasch, RC5
Wesbey, GE1
Engelstad, BL1
Lipton, MJ3
Lovin, J1
Bosiljanoff, P1
Feinendegen, LE1
Frenkel', VKh1
Morgunov, NB1
Kamenker, SM1
Filatova, NP1
Fedele, F1
Montesano, T1
Ferro-Luzzi, M1
Di Cesare, E1
Di Renzi, P1
Scopinaro, F1
Agati, L1
Penco, M1
Serri, F1
Vitarelli, A1
Edelman, RR3
Li, W1
Anderson, CM1
Brown, JJ1
Klein, MA1
Collier, BD1
Hellman, RS1
Bamrah, VS1
Wilke, N4
Simm, C1
Zhang, J1
Ellermann, J1
Ya, X1
Merkle, H2
Path, G1
Lüdemann, H1
Bache, RJ2
Uğurbil, K3
Tsekos, NV1
Zhang, Y2
Jerosch-Herold, M3
Stillman, A1
Kraitchman, DL1
Hexeberg, E1
Wang, Y2
Parrish, TB1
Chang, CN1
Axel, L1
Dixon, WT1
Oshinski, JN1
Trudeau, JD1
Arnold, BC1
Pettigrew, RI1
Demsar, F1
Roberts, TP1
Schwickert, HC1
Shames, DM1
van Dijke, CF1
Mann, JS1
Saeed, M6
Wendland, M2
Sakuma, H1
Szolar, D1
Geschwind, JF1
Maeda, A1
Seo, K1
Ogawa, K1
Iizuka, M1
Huang, Y1
Christensen, BV1
Stillman, AE1
McDonald, K1
Wilson, RF1
Lee, J1
Kim, KM1
Yeo, JS1
Cheon, GJ1
Kim, SK1
Ahn, JY1
Hemmingsson, A1
Bjerner, T1
Ericsson, A1
Johansson, L1
Ahlström, H1
Schaefer, S1
van Tyen, R1
Saloner, D1
Diesbourg, LD1
Prato, FS1
Wisenberg, G1
Drost, DJ1
Marshall, TP1
Carroll, SE1
O'Neill, B1
de Roos, A1
Mohanlal, RW1
van Vaals, JJ1
Bergman, AH1
Doornbos, J1
Matheijssen, NA1
van der Wall, EE1
van der Laarse, A1
Wendland, MF4
Cavagna, F1
Daprà, M1
Maggioni, F1
de Haën, C1
Felder, E1
Manning, WJ1
Atkinson, DJ2
Grossman, W1
Paulin, S1
Burstein, D1
Hart, AP1
Camporesi, EM1
Sell, TL1
Croughwell, N1
Silva, R1
Jones, RH1
McIntyre, RW1
Stanley, TE1
Reves, JG1
Wolfe, CL3
Kawamura, Y1
Yamazaki, J1
Okuzumi, I1
Muto, T1
Nakano, H1
Igarashi, M1
Aoki, R1
Uchi, T1
Iida, M1
Okamoto, K1
Miller, DD1
Holmvang, G1
Gill, JB1
Dragotakes, D1
Kantor, HL1
Okada, RD3
Brady, TJ2
Moseley, ME3
Wikstrom, MG1
Sievers, RE2
Dupon, JW1
Finkbeiner, WE1
Parmley, WW1
Tomei, E1
Rocklage, SM1
Quay, SC1
Wolfe, C1
Schmiedl, U1
Chew, WM1
Ogan, MD1
Engeseth, H1
Giubbini, R1
Metra, M1
Guerra, P1
La Canna, G1
Bissoli, G1
Arosio, G1
Niccoli, L1
Visioli, O1
Bestagno, M1
Mena, I1
Johnston, DL1
Liu, P1
Lauffer, RB1
Newell, JB1
Wedeen, VJ1
Rosen, BR1
Kaul, S1
Watson, DD1
Oliner, JD1
Weyman, AE1
Strauss, HW1
Runge, VM1
Clanton, JA1
Wehr, CJ1
Partain, CL1
James, AE1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Study of Myocardial Perfusion by MRI[NCT00001631]Phase 2249 participants Interventional1997-08-31Completed
Diagnostic Value of a Rapid Protocol Regadenoson Stress Cardiovascular Magnetic Resonance Scan for Detection of Coronary Artery Disease[NCT01446094]Phase 450 participants (Anticipated)Interventional2011-08-31Recruiting
Cardiac MRI for Metal on Metal Orthopaedic Prostheses[NCT02892448]35 participants (Actual)Interventional2016-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Cardiac Ejection Fraction

The volumetric fraction of fluid ejected from a chamber with each contraction. (NCT02892448)
Timeframe: Minimum 5 years post-operative

,,
InterventionPercent (Mean)
Left ventricular ejection fractionRight ventricular ejecton fraction
Bilateral Hip Resurfacing6663
Non-Metal on Metal Total Hip6562
Unilateral Hip Resurfacing6462

Cobalt and Chromium Ion Levels

To measure the level of cobalt and chromium ions in blood (NCT02892448)
Timeframe: Immediately Prior to cardiac MRI

,,
Interventionug/L (Mean)
Chromium blood levelsCobat blood levels
Bilateral Hip Resurfacing2.581.47
Non-Metal on Metal Total Hip0.110.18
Unilateral Hip Resurfacing1.410.71

Comprehensive Cardiac Function

Volume measures including: left ventricular end-diastolic volume, left ventricular stroke volume, right ventricular end-diastolic volume, right ventricular end-systolic volume, right ventricular stroke volume (NCT02892448)
Timeframe: One time measure at CMR

,,
InterventionmL/m^2 (Mean)
Left ventricle end-diastolic volume (LVEDV)Left ventricle end-systolic volume (LVESV)Left ventricle stroke volume (LVSV)Right ventricle end-diastolic volume (RVEDV)Right ventricle end-systolic volume (RVESV)Right ventricle stroke volume (RVSV)
Bilateral Hip Resurfacing732646823050
Non-Metal on Metal Total Hip672343712843
Unilateral Hip Resurfacing772751793053

T1 Mapping Time

T1 is a specific sequence in the cardiac MRI and mapping can lead to important indicators of cardiac structure and function. (NCT02892448)
Timeframe: One time measure at CMR

,,
Interventionms (Mean)
Native T1 left ventricle (LV) averagePost gadolinium T1 left ventricle (LV) average
Bilateral Hip Resurfacing988409
Non-Metal on Metal Total Hip993383
Unilateral Hip Resurfacing1003402

T2* Mapping Time

T2* is a specific sequence in the cardiac MRI and mapping can lead to important indicators of cardiac structure and function. (NCT02892448)
Timeframe: One time measure at CMR

,,
Interventionms (Mean)
MyocardiumLiver
Bilateral Hip Resurfacing3324
Non-Metal on Metal Total Hip3328
Unilateral Hip Resurfacing3227

Reviews

2 reviews available for pentetic acid and Coronary Disease

ArticleYear
Cardiovascular magnetic resonance imaging: evaluation of myocardial perfusion.
    Coronary artery disease, 1993, Volume: 4, Issue:4

    Topics: Animals; Contrast Media; Coronary Circulation; Coronary Disease; Coronary Vessels; Echo-Planar Imagi

1993
Assessment of myocardial ischemia and infarction by contrast enhanced magnetic resonance imaging.
    Cardiology clinics, 1989, Volume: 7, Issue:3

    Topics: Animals; Contrast Media; Coronary Circulation; Coronary Disease; Gadolinium DTPA; Humans; Magnetic R

1989

Trials

1 trial available for pentetic acid and Coronary Disease

ArticleYear
The effect of nitroglycerin on response to tracheal intubation. Assessment by radionuclide angiography.
    Anesthesia and analgesia, 1989, Volume: 68, Issue:6

    Topics: Coronary Circulation; Coronary Disease; Humans; Intubation, Intratracheal; Male; Middle Aged; Nitrog

1989

Other Studies

41 other studies available for pentetic acid and Coronary Disease

ArticleYear
Dosimetry in leakage of (188)Re-DTPA during intracoronary balloon brachytherapy.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:9

    Topics: Angioplasty, Balloon, Coronary; Body Burden; Brachytherapy; Catheterization; Coronary Disease; Extra

2003
[First-tracer passage with a single-crystal gamma camera: completed assessment of left-ventricular function by determining enddiastolic volume, regional ejection fraction and %-akinetic segment (author's transl)].
    Nuklearmedizin. Nuclear medicine, 1981, Volume: 20, Issue:3

    Topics: Cineradiography; Coronary Disease; Heart; Humans; Pentetic Acid; Radionuclide Imaging; Sodium Pertec

1981
Radionuclide ejection fraction: comparison of response to treadmill and bicycle exercise.
    European journal of nuclear medicine, 1982, Volume: 7, Issue:9

    Topics: Adult; Aged; Cardiac Output; Coronary Disease; Exercise Test; Humans; Middle Aged; Pentetic Acid; Ra

1982
[Left ventricular contractility studied by radionuclide ventriculography].
    Meditsinskaia radiologiia, 1984, Volume: 29, Issue:4

    Topics: Adult; Chronic Disease; Coronary Disease; Diphosphates; Heart; Heart Ventricles; Humans; Male; Middl

1984
First-pass radionuclide angiography via pulmonary arterial catheters. A critical analysis of background components.
    Radiology, 1984, Volume: 150, Issue:3

    Topics: Adult; Aged; Cardiac Output; Coronary Angiography; Coronary Disease; Female; Heart; Heart Function T

1984
Acute myocardial ischemia: magnetic resonance contrast enhancement with gadolinium-DTPA.
    Radiology, 1984, Volume: 153, Issue:1

    Topics: Animals; Coronary Disease; Dogs; Gadolinium; Magnetic Resonance Spectroscopy; Myocardial Contraction

1984
Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium.
    Radiology, 1984, Volume: 153, Issue:1

    Topics: Animals; Coronary Disease; Dogs; Gadolinium; Magnetic Resonance Spectroscopy; Myocardial Contraction

1984
[Assessment of haemodynamic parameters using non-triggered radioisotope methods (author's transl)].
    Nuklearmedizin. Nuclear medicine, 1981, Volume: 20, Issue:3

    Topics: Coronary Disease; Edetic Acid; Heart; Humans; Indium; Middle Aged; Pentetic Acid; Pulmonary Wedge Pr

1981
[Radionuclide double indicator method of determining indices of extravascular pulmonary fluid].
    Meditsinskaia radiologiia, 1982, Volume: 27, Issue:5

    Topics: Coronary Disease; Humans; Male; Middle Aged; Pentetic Acid; Pulmonary Edema; Radioisotopes; Radionuc

1982
Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: role of magnetic resonance imaging.
    American heart journal, 1994, Volume: 128, Issue:3

    Topics: Contrast Media; Coronary Disease; Fatty Acids; Female; Gadolinium; Gadolinium DTPA; Heart; Humans; M

1994
Contrast-enhanced echo-planar MR imaging of myocardial perfusion: preliminary study in humans.
    Radiology, 1994, Volume: 190, Issue:3

    Topics: Adult; Artifacts; Contrast Media; Coronary Circulation; Coronary Disease; Drug Combinations; Echo-Pl

1994
Detection of chronic coronary artery disease: value of pharmacologically stressed, dynamically enhanced turbo-fast low-angle shot MR images.
    AJR. American journal of roentgenology, 1993, Volume: 161, Issue:2

    Topics: Adult; Aged; Chronic Disease; Contrast Media; Coronary Angiography; Coronary Disease; Dipyridamole;

1993
Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia.
    Magnetic resonance in medicine, 1993, Volume: 29, Issue:4

    Topics: Animals; Contrast Media; Coronary Circulation; Coronary Disease; Dipyridamole; Dogs; Gadolinium; Gad

1993
Fast anatomical imaging of the heart and assessment of myocardial perfusion with arrhythmia insensitive magnetization preparation.
    Magnetic resonance in medicine, 1995, Volume: 34, Issue:4

    Topics: Algorithms; Animals; Arrhythmias, Cardiac; Contrast Media; Coronary Circulation; Coronary Disease; D

1995
Myocardial perfusion and function in dogs with moderate coronary stenosis.
    Magnetic resonance in medicine, 1996, Volume: 35, Issue:5

    Topics: Animals; Contrast Media; Coronary Circulation; Coronary Disease; Dobutamine; Dogs; Gadolinium DTPA;

1996
Myocardial suppression in vivo by spin locking with composite pulses.
    Magnetic resonance in medicine, 1996, Volume: 36, Issue:1

    Topics: Absorption; Blood; Contrast Media; Coronary Circulation; Coronary Disease; Electron Spin Resonance S

1996
Spatial mapping of microvascular permeability and tissue blood volume using magnetic resonance imaging.
    Academic radiology, 1996, Volume: 3 Suppl 2

    Topics: Adenocarcinoma; Albumins; Animals; Capillary Permeability; Contrast Media; Coronary Circulation; Cor

1996
Identification of regional myocardial ischemia using contrast-enhanced dynamic magnetic resonance imaging in an experimental canine model of hemodynamically significant coronary arterial stenosis.
    Academic radiology, 1996, Volume: 3 Suppl 2

    Topics: Animals; Contrast Media; Coronary Circulation; Coronary Disease; Dogs; Gadolinium DTPA; Hemodynamics

1996
[Assessment of myocardial perfusion hemodynamics using echo planar MR imaging].
    Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:7

    Topics: Coronary Circulation; Coronary Disease; Echo-Planar Imaging; Gadolinium DTPA; Humans; Image Enhancem

1997
Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging.
    Radiology, 1997, Volume: 204, Issue:2

    Topics: Animals; Cardiac Catheterization; Contrast Media; Coronary Angiography; Coronary Circulation; Corona

1997
Dosimetry of rhenium-188 diethylene triamine penta-acetic acid for endovascular intra-balloon brachytherapy after coronary angioplasty.
    European journal of nuclear medicine, 2000, Volume: 27, Issue:1

    Topics: Angioplasty, Balloon, Coronary; Animals; Brachytherapy; Coronary Disease; Dogs; Pentetic Acid; Radio

2000
Contrast agents in acute myocardial infarction.
    Magma (New York, N.Y.), 2001, Volume: 12, Issue:2-3

    Topics: Contrast Media; Coronary Disease; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Myocardial In

2001
Evaluation of myocardial perfusion abnormalities with gadolinium-enhanced snapshot MR imaging in humans. Work in progress.
    Radiology, 1992, Volume: 185, Issue:3

    Topics: Adult; Aged; Contrast Media; Coronary Angiography; Coronary Circulation; Coronary Disease; Dipyridam

1992
Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease.
    Magnetic resonance in medicine, 1992, Volume: 23, Issue:2

    Topics: Animals; Contrast Media; Coronary Circulation; Coronary Disease; Dogs; Female; Gadolinium; Gadoliniu

1992
Gadolinium-DTPA-enhanced magnetic resonance imaging of the isolated rat heart after ischemia and reperfusion.
    Investigative radiology, 1991, Volume: 26, Issue:12

    Topics: Animals; Contrast Media; Coronary Disease; Evans Blue; Gadolinium DTPA; In Vitro Techniques; Magneti

1991
Strategies for differential enhancement of myocardial ischemia using echoplanar imaging.
    Investigative radiology, 1991, Volume: 26 Suppl 1

    Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Female; Gadolinium; Gadolinium DTPA; Image En

1991
Gd-BOPTA/Dimeg: experimental disease imaging.
    Magnetic resonance in medicine, 1991, Volume: 22, Issue:2

    Topics: Acetates; Animals; Contrast Media; Coronary Disease; Gadolinium; Gadolinium DTPA; Liver Neoplasms, E

1991
Contrast enhancement for the myocardium.
    Magnetic resonance in medicine, 1991, Volume: 22, Issue:2

    Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Gadolinium; Gadolinium DTPA; Humans; Magnetic

1991
First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease.
    Journal of the American College of Cardiology, 1991, Volume: 18, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Cardiac Catheterization; Constriction, Pathologic; Contrast Media; C

1991
Magnetic resonance contrast media for myocardial imaging.
    Investigative radiology, 1990, Volume: 25 Suppl 1

    Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonan

1990
First-pass cardiac perfusion: evaluation with ultrafast MR imaging.
    Radiology, 1990, Volume: 174, Issue:3 Pt 1

    Topics: Animals; Contrast Media; Coronary Circulation; Coronary Disease; Gadolinium; Gadolinium DTPA; Heart;

1990
[Clinical application of 99mTc-DTPA-HSA--comparison with 99mTc-human serum albumin].
    Kaku igaku. The Japanese journal of nuclear medicine, 1989, Volume: 26, Issue:3

    Topics: Aged; Coronary Disease; Female; Heart; Humans; Male; Middle Aged; Pentetic Acid; Radionuclide Angiog

1989
MRI detection of myocardial perfusion changes by gadolinium-DTPA infusion during dipyridamole hyperemia.
    Magnetic resonance in medicine, 1989, Volume: 10, Issue:2

    Topics: Animals; Contrast Media; Coronary Circulation; Coronary Disease; Dipyridamole; Disease Models, Anima

1989
Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy.
    Circulation, 1989, Volume: 80, Issue:4

    Topics: Albumins; Animals; Coronary Disease; Gadolinium; Gadolinium DTPA; Histocytochemistry; Magnetic Reson

1989
Demarcation of myocardial ischemia: magnetic susceptibility effect of contrast medium in MR imaging.
    Radiology, 1989, Volume: 173, Issue:3

    Topics: Animals; Blood Pressure; Contrast Media; Coronary Disease; Dysprosium; Heart Rate; Magnetic Resonanc

1989
Acute myocardial ischemia and reperfusion: MR imaging with albumin-Gd-DTPA.
    Radiology, 1989, Volume: 170, Issue:2

    Topics: Animals; Coronary Disease; Gadolinium DTPA; Heart; Magnetic Resonance Imaging; Microspheres; Myocard

1989
Diagnostic accuracy of rest-exercise first pass ventriculography with a fast single crystal gamma camera in detecting coronary artery disease. Study of a group of male subjects without previous myocardial infarction.
    European journal of nuclear medicine, 1987, Volume: 13, Issue:5

    Topics: Adult; Aged; Angina Pectoris; Cardiac Output; Coronary Disease; Exercise Test; Heart Ventricles; Hum

1987
Nuclear medicine: non-invasive evaluation of coronary artery disease.
    Annals of the Academy of Medicine, Singapore, 1986, Volume: 15, Issue:4

    Topics: Cardiac Output; Coronary Circulation; Coronary Disease; Exercise Test; Gold Radioisotopes; Heart Ven

1986
Use of gadolinium-DTPA as a myocardial perfusion agent: potential applications and limitations for magnetic resonance imaging.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1987, Volume: 28, Issue:5

    Topics: Animals; Contrast Media; Coronary Circulation; Coronary Disease; Dipyridamole; Dogs; Gadolinium; Gad

1987
Relationship between left ventricular systolic function and plasma clearance of 169Yb-DTPA in normal and ischemic dogs.
    Nephron, 1987, Volume: 47, Issue:2

    Topics: Animals; Blood Pressure; Coronary Disease; Dogs; Glomerular Filtration Rate; Heart Rate; Pentetic Ac

1987
Gated magnetic resonance imaging of acute myocardial ischemia in dogs: application of multiecho techniques and contrast enhancement with GD DTPA.
    Magnetic resonance imaging, 1985, Volume: 3, Issue:3

    Topics: Animals; Coronary Circulation; Coronary Disease; Dogs; Electrocardiography; Female; Gadolinium; Magn

1985